Skip to content

SELLAS Life Sciences Group, Inc. SLS Prepaid & Other Current

Prepaid & Other Current at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$16.1M+90.3%
AbbVie logo
AbbVieABBV
$150M-97.3%
Immunome logo
ImmunomeIMNM
$11.62M+100%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$11.43M+58.2%
Incyte logo
IncyteINCY
$301.31M+42.4%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$12.93M-18.7%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s prepaid & other current?
SELLAS Life Sciences Group, Inc. (SLS) reported prepaid & other current of $3.97M in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s prepaid & other current changed year-over-year?
SELLAS Life Sciences Group, Inc.'s prepaid & other current increased by 14.3% year-over-year, from $3.48M to $3.97M.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s prepaid & other current has grown at a 53.1% compound annual growth rate (CAGR), from $395K to $3.32M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.